Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $-0.34 · Revenue $962000.00 · 2 analysts
Est. EPS $-0.35 · Revenue $1.13M · 2 analysts
Est. EPS $-1.83 · Revenue $2.96M · 1 analysts
Est. EPS $-0.30 · Revenue $1.07M · 1 analysts
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $1.0M | -18.3% | +18.9% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-17.1M | -55.0% | +4.1% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | -19.7% | -156.6% | +2047.6% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -1053.1% | +6.6% | +24.3% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -1678.1% | -89.7% | +19.4% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $-8.8M | +6.1% | -14.1% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | -860.5% | -14.9% | +4.0% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 110.9% | +7.3% | -82.5% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 1.51x | -37.1% | +127.7% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $9.5M | +1.0% | +33.5% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -6.16 vs -6.06 | -1.7% | -0.75 vs -0.73 | -2.7% |
| Revenue Surprise | $1.0M vs $1.1M | -7.3% | $452000 vs $460000 | -1.7% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Elmore Robert Ryan | officer: President | Common Stock | A | 4,910 | $2.88 |
| Mar 16, 2026 | Elmore Robert Ryan | officer: President | Restricted Stock Units | A | 107,143 | — |
| Mar 2, 2026 | Lyons Christopher Michael | director | Common Stock | A | 7,534 | $2.90 |
| Feb 25, 2026 | Lyons Christopher Michael | director | Common Stock | A | 758 | $2.96 |
| Feb 23, 2026 | MOYES JAY M | director | Common Stock | A | 1,000 | $2.91 |
Operator : Good day, and welcome to the SINTX Technologies Second Quarter 2026 Earnings Call. [Operator Instructions] As a reminder, today's call is being recorded. I would like to turn the call over to SINTX Technologies Chief Legal Officer, Kevin Ontiveros. Kevin Ontiveros : Thank you, operator, and good afternoon, everyone. Earlier today, SINTX Technologies issued its financial results for the quarter ended June 30, 2026, and filed its quarterly report on Form 10-Q with the Securities and Exchange Commission. The earnings release and Form 10-Q are available in the Investor Relations section of the company's website, and a replay of this call will be available following the conclusion of today's event. Before we begin, I would like to remind everyone that statements made during this call that are not statements of historical fact, are forward-looking statements. These statements include, among other things, expectations regarding revenue growth, customer orders, production and shipping timing, commercialization, market adoption, strategic relationships, operating performance, cost management, liquidity, financing, future business opportunities, and revenue guidance and expectations regarding the timing and amount of revenue recognition. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Please refer to the company's most recent Form 10-K, today's Form 10-Q, and other filings with the SEC for a discussion of these risks. SINTX undertakes no obligation to update forward-looking statements except as required by law. Unless otherwise stated, the financial results discussed today are presented in accordance with U.S. generally accepted accounting principles. Joining today's call are Eric Olson, Chairman and Chief Executive Officer; and Kevin Trask, Chief Financial Officer. Eric will begin with a review of the quarter and the company's commercial priorities. Kevin will then discuss the financial results and liquidity. Eric will conclude with the priorities for the remainder of 2026. Eric, please go ahead. Eric Olson : Thank you, Kevin, and thank you to everyone joining us today. The second quarter represented meaningful progress in SINTX's transition from a development company to a commercially-focused biomaterials and medical technology platform company. Our financial results show that commercial activity is beginning to become more visible. We also make clear that our work is not complete. We must convert demand into revenue, establish repeatable medical device commercialization efforts, align our cost structure with the scale of the business, and maintain adequate liquidity. So let me begin with 3 key takeaways from the quarter. First, commercial activity is beginning to show up in our reported results. Second quarter revenue increased 199% year-over-year to $452,000. And product revenue …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Eric K. Olson | CEO & Chairman of the Board | USD 541,360 | Male | 1963 | Active |
Gregg Richard Honigblum | Chief Investment Officer & Director | USD 471,272 | Male | 1963 | Active |
Kevin J. Ontiveros | Chief Legal Officer | USD 298,248 | Male | 1960 | Active |
Kevin Trask | Chief Financial Officer | USD 283,800 | Male | 1986 | Active |
Ryan Elmore | President | — | Male | 1975 | Active |
Lisa Marie Del Re | Chief Commercial Officer | — | Female | — | Active |
SINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a company focused on advanced silicon nitride materials and medical technologies, today announced that it received written notification from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain minimum stockholders' equity of $2.5 million. Based on SINTX's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which reported stockholders' equity of approximately $4.83 million, Nasdaq determined that the Company complies with the minimum stockholders' equity requirement under Listing Rule 5550(b)(1) and confirmed that the previously disclosed deficiency matter is now closed.
Sintx Technologies, Inc. (SINT) Q2 2026 Earnings Call Prepared Remarks Transcript
SALT LAKE CITY, Utah, Aug. 11, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today provided a business update in conjunction with the filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. During the first half of 2026, SINTX advanced the commercialization of its FDA-cleared SiNAPTIC® Foot & Ankle Implant System, expanded its commercial distribution network, raised additional capital, invested in advanced manufacturing capabilities, and continued to broaden the application of its proprietary silicon nitride technology platform across multiple healthcare and industrial markets.
SALT LAKE CITY, Utah, July 28, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride ceramics and advanced material technologies, today announced that it will release its second quarter 2026 financial results on Tuesday, August 11, 2026, after the market close. The Company will also host a conference call and webcast that day at 4:30 p.m.
